awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53209584-A3B28BE9-80D4-40E3-B4A8-E6636BEDC78E
Q53209584-A3B28BE9-80D4-40E3-B4A8-E6636BEDC78E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53209584-A3B28BE9-80D4-40E3-B4A8-E6636BEDC78E
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors.
P2860
Q53209584-A3B28BE9-80D4-40E3-B4A8-E6636BEDC78E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53209584-A3B28BE9-80D4-40E3-B4A8-E6636BEDC78E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1c46833e04543da18fb2133c65b7e70ab45bec9
P2860
PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup